Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for Postoperative Pain in Total Knee Replacement
NCT06187922Phase 4Recruiting
- Sponsor
- Bahrain Defence Force Hospital
- Start
- Sep 2023
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of pregabalin in postoperative pain (2 arms), sponsored by Bahrain Defence Force Hospital. Primary endpoint: Visual Analogue Scale Score at 72 hours. Started Sep 2023; status: recruiting.
02
Drugs
pregabalin
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06187922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06187922.